• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨 5-氟尿嘧啶相关毒性的 、 和 多态性在结直肠癌中的作用。

Investigation of , and polymorphisms on 5-fluorouracil related toxicities in colorectal cancer.

机构信息

Department of Molecular Biology, Marmara University Faculty of Arts and Science, Istanbul, 34722, Turkey.

Department of Medical Oncology, Demiroglu Bilim University Faculty of Medicine, Istanbul, 34394, Turkey.

出版信息

Per Med. 2022 Sep;19(5):435-444. doi: 10.2217/pme-2021-0047. Epub 2022 Jul 26.

DOI:10.2217/pme-2021-0047
PMID:35880438
Abstract

To investigate the association of , and polymorphisms on 5-fluorouracil (5-FU) related toxicities and patient survival. A total of 103 colorectal cancer patients prescribed 5-FU were included in the study. Genotyping was conducted for several , and polymorphisms using a microarray analyzer. 496A>G polymorphism was found to be significantly associated with 5-FU related grade 0-2, but not severe toxicities (p = 0.02). Furthermore, patients with 85TC and CC genotypes had longer progression and overall survival times compared to TT genotypes in our study group (log rank = 6.60; p = 0.01 and log rank = 4.40; p = 0.04, respectively). According to our results, 496AG and GG genotypes might be protective against severe adverse events compared to the AA genotype. Another polymorphism, 85T>C, may be useful in colorectal cancer prognosis. Further studies for both polymorphisms should be conducted in larger populations to achieve accurate results.

摘要

为了研究 、 和 多态性与 5-氟尿嘧啶(5-FU)相关毒性和患者生存的关联。本研究纳入了 103 名接受 5-FU 治疗的结直肠癌患者。使用微阵列分析仪对几种 、 和 多态性进行了基因分型。496A>G 多态性与 5-FU 相关的 0-2 级毒性显著相关,但与严重毒性无关(p=0.02)。此外,与 TT 基因型相比,85TC 和 CC 基因型的患者在我们的研究组中具有更长的进展和总生存时间(对数秩检验=6.60;p=0.01 和对数秩检验=4.40;p=0.04)。根据我们的结果,与 AA 基因型相比,496AG 和 GG 基因型可能对严重不良事件具有保护作用。另一种 多态性 85T>C 可能对结直肠癌的预后有用。应在更大的人群中对这两种多态性进行进一步研究,以获得准确的结果。

相似文献

1
Investigation of , and polymorphisms on 5-fluorouracil related toxicities in colorectal cancer.探讨 5-氟尿嘧啶相关毒性的 、 和 多态性在结直肠癌中的作用。
Per Med. 2022 Sep;19(5):435-444. doi: 10.2217/pme-2021-0047. Epub 2022 Jul 26.
2
Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity.韩国人群中胸苷酸合成酶(TYMS)和二氢嘧啶脱氢酶(DPYD)基因多态性对预测5-氟尿嘧啶相关毒性的研究
Ther Drug Monit. 2007 Apr;29(2):190-6. doi: 10.1097/FTD.0b013e318040b1fe.
3
The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer.叶酸代谢基因多态性与结直肠癌辅助化疗反应的关系。
Cancer Chemother Pharmacol. 2018 Aug;82(2):237-243. doi: 10.1007/s00280-018-3608-6. Epub 2018 May 29.
4
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.遗传和非遗传因素在氟尿嘧啶治疗相关严重毒性中的作用:德国5-氟尿嘧啶毒性研究组的一项前瞻性临床试验
J Clin Oncol. 2008 May 1;26(13):2131-8. doi: 10.1200/JCO.2006.10.4182. Epub 2008 Feb 25.
5
DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer.DPYD*2A 和 MTHFR C677T 分别预测结直肠癌患者接受氟尿嘧啶化疗的毒性和疗效。
Cancer Chemother Pharmacol. 2018 Jan;81(1):119-129. doi: 10.1007/s00280-017-3478-3. Epub 2017 Nov 13.
6
Variants in the dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidylate synthase genes predict early toxicity of 5-fluorouracil in colorectal cancer patients.二氢嘧啶脱氢酶、亚甲基四氢叶酸还原酶和胸苷酸合成酶基因的变异可预测结直肠癌患者中5-氟尿嘧啶的早期毒性。
J Int Med Res. 2010 May-Jun;38(3):870-83. doi: 10.1177/147323001003800313.
7
and polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients.以及多态性作为预测结直肠癌患者氟尿嘧啶毒性的标志物。
J Chemother. 2023 Sep;35(5):425-434. doi: 10.1080/1120009X.2022.2125736. Epub 2022 Sep 22.
8
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS.一项关于结直肠癌中卡培他滨相关毒性的候选基因研究在二氢嘧啶脱氢酶(DPYD)基因中发现了新的毒性变异,并确定了烯醇化酶超家族成员1(ENOSF1)而非胸苷酸合成酶(TYMS)的假定作用。
Gut. 2015 Jan;64(1):111-20. doi: 10.1136/gutjnl-2013-306571. Epub 2014 Mar 19.
9
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.亚甲基四氢叶酸还原酶(MTHFR)基因多态性与结直肠癌患者 FOLFOX 反应的关系。
Br J Clin Pharmacol. 2010 Jan;69(1):58-66. doi: 10.1111/j.1365-2125.2009.03556.x.
10
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer.二氢嘧啶脱氢酶和胸苷酸合成酶基因多态性及其与结直肠癌5-氟尿嘧啶/亚叶酸化疗的相关性
Clin Colorectal Cancer. 2004 Feb;3(4):225-34. doi: 10.3816/CCC.2004.n.003.

引用本文的文献

1
Pharmacogenetics of DPYD and treatment-related mortality on fluoropyrimidine chemotherapy for cancer patients: a meta-analysis and trial sequential analysis.DPYD 药物遗传学与癌症患者氟嘧啶化疗相关死亡率:荟萃分析和试验序贯分析。
BMC Cancer. 2024 Sep 30;24(1):1210. doi: 10.1186/s12885-024-12981-5.
2
Gene Polymorphism Modifies the Effect of Common Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy.基因多态性改变了常见基因变异对接受氟嘧啶类抗癌治疗的胃肠道肿瘤患者严重毒性的影响。
Int J Mol Sci. 2024 Aug 4;25(15):8503. doi: 10.3390/ijms25158503.
3
Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study.
遗传多态性和肿瘤突变特征对晚期结直肠癌患者生存的影响:一项探索性研究。
Curr Oncol. 2024 Jan 3;31(1):274-295. doi: 10.3390/curroncol31010018.